Concepedia

Carolyn Biles

CB

11

Publications

1.2K

Citations

11

H-Index

1975

Active since

Affiliations

W.E. Upjohn Institute for Employment Research(Current)

Carolyn Biles is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1975–2000

11

Publications

11

Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant:  Lead Identification and SAR of 3- and 4-Substituted Derivatives

Michaël Génin, Carolyn Biles, Barb J. Keiser et al. · Journal of Medicinal Chemistry · 2000 · 375 citations · Full text

CC-1065(NSC 298223), a potent new antitumor agent. Improved production and isolation, characterization and antitumor activity.

David G. Martin, Carolyn Biles, S. A. Gerpheide et al. · The Journal of Antibiotics · 1981 · 140 citations · Full text

Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogs and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)carbonyl]-4-[3-[(1-methylethyl)amino]pyridinyl]piperazinemonomethanesulfonate (U-90152S), a second-generation clinical candidate

Donna L. Romero, Raymond A. Morge, Michaël Génin et al. · Journal of Medicinal Chemistry · 1993 · 123 citations · Full text

, , +18

Primary cultures of hepatocytes on human fibroblasts

George K. Michalopoulos, F.E. Russell, Carolyn Biles · In Vitro Cellular & Developmental Biology - Plant · 1979 · 119 citations

, , +8

Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors

Donna L. Romero, Raymond A. Morge, Carolyn Biles et al. · Journal of Medicinal Chemistry · 1994 · 90 citations

, , +13

Rows per page

1–5 of 11